IDEXX LABORATORIES INC /DE — Director's Dealing 2020

Aug 18, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2020-08-14

Reporting Person: Claflin Bruce L. (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-08-14	Common Stock	S	1111	$378.08	Disposed	304	Direct
2020-08-17	Common Stock	M	5629	$70.54	Acquired	5933	Direct
2020-08-18	Common Stock	S	5629	$385.1133	Disposed	304	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-08-17	Non-Qualified Stock Option (right-to-buy)	$70.54	M	5629	Disposed	2025-08-31	Common Stock (5629)	Direct

Footnotes

F1: Represents the weighted average price of the shares sold ranging from a low of $384.90 to a high of $385.765 per share. The undersigned undertakes, upon a request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.

F2: Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that vested in one installment on the date of the 2016 annual meeting of shareholders.

F3: Not applicable.